AMP Capital Investors’s Ascendis Pharma A/S ASND Stock Holding History

AMP Capital Investors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,220	Closed	-$1.32M	–	1162
2021 Q1	$1.32M	Hold	10,220	–	–	0.01%	816
2020 Q4	$1.74M	Hold	10,220	–	–	0.01%	776
2020 Q3	$1.56M	Sell	10,220 -390	-4%	-$56.1K	0.01%	751
2020 Q2	$1.54M	Hold	10,610	–	–	0.01%	746
2020 Q1	$1.23M	Buy	+10,610	New	+$1.38M	0.01%	753

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AMP Capital Investors's ASND Position: Q2 2021 in Review

AMP Capital Investors sold out of Ascendis Pharma A/S (ASND) in Q2 2021, closing a stake of 10,220 shares — an estimated $1.32M sold.

AMP Capital Investors first reported a position in ASND in Q1 2020 and held it in 5 quarters. The position peaked at $1.74M in Q4 2020. 171 funds tracked by Wall St. Rank hold ASND as of Q2 2021.

AMP Capital Investors reported no remaining Ascendis Pharma A/S position as of Q2 2021 after selling out during the quarter.
AMP Capital Investors sold 10,220 Ascendis Pharma A/S shares in Q2 2021, an estimated $1.32M.
AMP Capital Investors first reported a position in Ascendis Pharma A/S in Q1 2020 and held it in 5 quarters.
AMP Capital Investors's Ascendis Pharma A/S position peaked at $1.74M in Q4 2020.
171 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2021.

Based on AMP Capital Investors's 13F filing for Q2 2021, filed 16 Aug 2021.